NEVVI Medicare utilization intelligence
or

← back

Provider profile

CUBERO REGO, DAVID M.D.

Pathology · NPI 1134584543 · FORT MYERS, FL

1
Groups
25
Codes · 2024
48,376
Disclosed services

CUBERO REGO, DAVID is a Pathology in FORT MYERS, FL, a member of 1 medical group, who billed 25 distinct codes to Medicare Part B in 2024.

Groups: AMERICAN ONCOLOGY PARTNERS PA (FORT WAYNE, IN)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒

Provider overview · all codes · CY2024

48,376
disclosed services
25
codes billed to Medicare Part B
Prior year · CY2023 46,926 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
88185 Flow cytometry technique for dna or cell analysis, each additional marker
88341 Special stained specimen slides to examine tissue, each additional procedure
84165 Protein measurement, serum
88374 Microscopic genetic analysis of tissue, computer-assisted technology, initial procedure, each multiplex procedure
88313 Special stained specimen slides to examine tissue including interpretation and report
86334 Immunologic analysis technique on serum (immunofixation)
88184 Flow cytometry technique for dna or cell analysis, first marker
88189 Flow cytometry technique for dna or cell analysis, 16 or more markers
88305 Pathology examination of tissue using a microscope, intermediate complexity
88342 Special stained specimen slides to examine tissue, initial procedure
88311 Preparation of tissue for examination by removing any calcium present
G0452 Molecular pathology procedure; physician interpretation and report
85097 Bone marrow, smear interpretation
81279 Gene analysis (janus kinase 2) targeted sequence analysis
81338 Gene analysis (mpl proto-oncogene, thrombopoietin receptor) for detection of common variants
81219 Gene analysis (calreticulin), common variants
81270 Gene analysis (janus kinase 2) variant
88360 Microscopic genetic analysis of tumor, manual
88160 Screening examination of specimen cells, screening and interpretation
81206 Translocation analysis (bcr/abl1) major breakpoint
81207 Translocation analysis (bcr/abl1) minor breakpoint
81208 Translocation analysis (bcr/abl1) other breakpoint
88364 Genetic sequencing localization, each additional procedure
88365 Genetic sequencing localization, initial procedure
88187 Flow cytometry technique for dna or cell analysis, 2 to 8 markers

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.